NEW YORK, Sept. 12, 2022 /PRNewswire/ -- Catalyst Pharmaceuticals Inc. (NASD:CPRX) will replace Mantech International Corp. (NASD:MANT) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, September 15. The Carlyle Group Inc. (NASD:CG) is acquiring ManTech International in a transaction expected to be completed soon pending final conditions.
Read more at prnewswire.comCatalyst Pharmaceuticals Set to Join S&P SmallCap 600
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here